A 17 year old female with von Willebrand disease presents for dental extraction the appropriate prior line of management include
**Question:** A 17 year old female with von Willebrand disease presents for dental extraction the appropriate prior line of management include
A. Transfusion therapy
B. Antibiotic prophylaxis
C. Local hemostatic agents
D. Intravenous immunoglobulin (IVIG)
**Correct Answer:** C. Local hemostatic agents
**Core Concept:** Von Willebrand disease (VWD) is an inherited bleeding disorder resulting from a deficiency or dysfunction of von Willebrand factor (VWF), a protein involved in platelet function and clotting. VWD can cause prolonged bleeding episodes, especially during dental procedures due to impaired hemostasis.
**Why the Correct Answer is Right:** Local hemostatic agents like tranexamic acid, epsilon aminocaproic acid (EACA), and aminocaproic acid are administered to reduce bleeding during dental procedures in patients with VWD. These agents inhibit plasmin, a fibrinolytic enzyme, thereby preventing breakdown of the fibrin clot and promoting hemostasis.
**Why Each Wrong Option is Incorrect:**
A. Transfusion therapy (transfusion of blood products) is often not suitable due to the risk of allergic reactions, viral infections, and the possibility of exacerbating bleeding in VWD patients.
B. Antibiotic prophylaxis does not address the underlying issue of impaired hemostasis in VWD patients and is not an effective method of preventing bleeding during dental procedures.
D. Intravenous immunoglobulin (IVIG) is a plasma product containing various immunoglobulins and is used for immune modulation in certain autoimmune disorders. IVIG does not specifically target the management of bleeding disorders like VWD and is not the first-line treatment for dental procedures in VWD patients.
**Clinical Pearl:** A thorough pre-procedure consultation with a hematologist or bleeding disorder specialist is essential for an appropriate plan of action in patients with VWD undergoing dental procedures. Consideration of local hemostatic agents, such as tranexamic acid, epsilon aminocaproic acid (EACA), or aminocaproic acid, may be necessary to reduce bleeding risk during dental interventions in VWD patients.